๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Soft Tissue Sarcoma
Clinical trial register · China

Soft Tissue Sarcoma Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 3 Beijing 3 Shanghai 3 Hangzhou 2 Zhengzhou 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou3 Beijing3 Shanghai3 Hangzhou2 Zhengzhou1
All 11 locations
Target enrolment
to

Soft Tissue Sarcoma trials in China

10 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas
NCT07052383Osteosarcoma, Soft Tissue Sarcoma
Tcelltech Inc.
Phase 1
15
Shanghai
2025-11-06
Recruiting
Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma
NCT07243626Soft Tissue Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
25
Hanzhong
2024-09-30
Recruiting
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
NCT06506838Soft Tissue Sarcoma, Doxorubicin, Radiotherapy
Guangdong Provincial People's Hospital
Phase 4
39
Guangzhou
2024-08-10
Not yet open
TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors
NCT06500091Soft Tissue Sarcoma, Melanoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
54
Beijing, Zhengzhou, Changsha, Changchun, Jinan, Shanghai, Taiyuan, Tianjin
2024-07
Recruiting
Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment
NCT05926700Soft Tissue Sarcoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
27
Hangzhou
2024-02-28
Recruiting
Safety and Efficacy of Preoperative SBRT and Radical Surgery for Soft Tissue Sarcoma of Extremities
NCT06760221Soft Tissue Sarcoma, Stereotactic Body Radiotherapy, Surgery
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
20
Hangzhou
2023-03-23
Recruiting
Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01)
NCT05224934Soft Tissue Sarcoma, Retroperitoneal Sarcoma, Radiotherapy Side Effect, Ultra-hypofractionated Radiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
50
Beijing
2022-01-01
Recruiting
Toripalimab Combined With CAV/IE Regimen
NCT04589741Soft Tissue Sarcoma
Sun Yat-sen University
Phase 2
134
Guangzhou
2020-10-23
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)
NCT03016819Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma, Soft-Tissue Sarcoma
Advenchen Laboratories, LLC
Phase 3
325
Beijing, Shanghai
2017-08-15
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/soft-tissue-sarcoma

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies listing the condition Soft Tissue Sarcoma.

How many Soft Tissue Sarcoma trials are recruiting in China?

9 of the 10 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Soft Tissue Sarcoma), 10 studies
PhaseStudiesRecruitingShare
Phase 25450%
Not applicable2220%
Phase 11110%
Phase 31110%
Phase 41110%

Most active sponsors

Lead sponsors with the most studies (Soft Tissue Sarcoma)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine33
Advenchen Laboratories, LLC11
Cancer Institute and Hospital, Chinese Academy of Medical Sciences11
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.10
Guangdong Provincial People's Hospital11
Sun Yat-sen University11
Tcelltech Inc.11
Yizhuo Zhang11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.